Global Favipiravir Market Research Report 2025(Status and Outlook)
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
The global Favipiravir market size was estimated at USD 342.05 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of -0.22% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Favipiravir market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Favipiravir market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Favipiravir market.
Global Favipiravir Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Market Segmentation (by Type)
Brand Drug
Generic Drug
Market Segmentation (by Application)
Influenza Viruses
COVID-19
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Favipiravir Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Favipiravir, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Favipiravir market size was estimated at USD 342.05 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of -0.22% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Favipiravir market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Favipiravir market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Favipiravir market.
Global Favipiravir Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Market Segmentation (by Type)
Brand Drug
Generic Drug
Market Segmentation (by Application)
Influenza Viruses
COVID-19
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Favipiravir Market
- Overview of the regional outlook of the Favipiravir Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Favipiravir Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Favipiravir, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Favipiravir
1.2 Key Market Segments
1.2.1 Favipiravir Segment by Type
1.2.2 Favipiravir Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 FAVIPIRAVIR MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Favipiravir Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Favipiravir Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 FAVIPIRAVIR MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Favipiravir Product Life Cycle
3.3 Global Favipiravir Sales by Manufacturers (2020-2025)
3.4 Global Favipiravir Revenue Market Share by Manufacturers (2020-2025)
3.5 Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Favipiravir Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Favipiravir Market Competitive Situation and Trends
3.8.1 Favipiravir Market Concentration Rate
3.8.2 Global 5 and 10 Largest Favipiravir Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 FAVIPIRAVIR INDUSTRY CHAIN ANALYSIS
4.1 Favipiravir Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF FAVIPIRAVIR MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Favipiravir Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Favipiravir Market
5.7 ESG Ratings of Leading Companies
6 FAVIPIRAVIR MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Favipiravir Sales Market Share by Type (2020-2025)
6.3 Global Favipiravir Market Size Market Share by Type (2020-2025)
6.4 Global Favipiravir Price by Type (2020-2025)
7 FAVIPIRAVIR MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Favipiravir Market Sales by Application (2020-2025)
7.3 Global Favipiravir Market Size (M USD) by Application (2020-2025)
7.4 Global Favipiravir Sales Growth Rate by Application (2020-2025)
8 FAVIPIRAVIR MARKET SALES BY REGION
8.1 Global Favipiravir Sales by Region
8.1.1 Global Favipiravir Sales by Region
8.1.2 Global Favipiravir Sales Market Share by Region
8.2 Global Favipiravir Market Size by Region
8.2.1 Global Favipiravir Market Size by Region
8.2.2 Global Favipiravir Market Size Market Share by Region
8.3 North America
8.3.1 North America Favipiravir Sales by Country
8.3.2 North America Favipiravir Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Favipiravir Sales by Country
8.4.2 Europe Favipiravir Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Favipiravir Sales by Region
8.5.2 Asia Pacific Favipiravir Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Favipiravir Sales by Country
8.6.2 South America Favipiravir Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Favipiravir Sales by Region
8.7.2 Middle East and Africa Favipiravir Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 FAVIPIRAVIR MARKET PRODUCTION BY REGION
9.1 Global Production of Favipiravir by Region(2020-2025)
9.2 Global Favipiravir Revenue Market Share by Region (2020-2025)
9.3 Global Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Favipiravir Production
9.4.1 North America Favipiravir Production Growth Rate (2020-2025)
9.4.2 North America Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Favipiravir Production
9.5.1 Europe Favipiravir Production Growth Rate (2020-2025)
9.5.2 Europe Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Favipiravir Production (2020-2025)
9.6.1 Japan Favipiravir Production Growth Rate (2020-2025)
9.6.2 Japan Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Favipiravir Production (2020-2025)
9.7.1 China Favipiravir Production Growth Rate (2020-2025)
9.7.2 China Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 ChemRar Group
10.1.1 ChemRar Group Basic Information
10.1.2 ChemRar Group Favipiravir Product Overview
10.1.3 ChemRar Group Favipiravir Product Market Performance
10.1.4 ChemRar Group Business Overview
10.1.5 ChemRar Group SWOT Analysis
10.1.6 ChemRar Group Recent Developments
10.2 Glenmark
10.2.1 Glenmark Basic Information
10.2.2 Glenmark Favipiravir Product Overview
10.2.3 Glenmark Favipiravir Product Market Performance
10.2.4 Glenmark Business Overview
10.2.5 Glenmark SWOT Analysis
10.2.6 Glenmark Recent Developments
10.3 Fujifilm
10.3.1 Fujifilm Basic Information
10.3.2 Fujifilm Favipiravir Product Overview
10.3.3 Fujifilm Favipiravir Product Market Performance
10.3.4 Fujifilm Business Overview
10.3.5 Fujifilm SWOT Analysis
10.3.6 Fujifilm Recent Developments
10.4 Dr. Reddy
10.4.1 Dr. Reddy Basic Information
10.4.2 Dr. Reddy Favipiravir Product Overview
10.4.3 Dr. Reddy Favipiravir Product Market Performance
10.4.4 Dr. Reddy Business Overview
10.4.5 Dr. Reddy Recent Developments
10.5 R-Pharma
10.5.1 R-Pharma Basic Information
10.5.2 R-Pharma Favipiravir Product Overview
10.5.3 R-Pharma Favipiravir Product Market Performance
10.5.4 R-Pharma Business Overview
10.5.5 R-Pharma Recent Developments
10.6 Cipla
10.6.1 Cipla Basic Information
10.6.2 Cipla Favipiravir Product Overview
10.6.3 Cipla Favipiravir Product Market Performance
10.6.4 Cipla Business Overview
10.6.5 Cipla Recent Developments
10.7 Lupin
10.7.1 Lupin Basic Information
10.7.2 Lupin Favipiravir Product Overview
10.7.3 Lupin Favipiravir Product Market Performance
10.7.4 Lupin Business Overview
10.7.5 Lupin Recent Developments
10.8 Sun Pharma
10.8.1 Sun Pharma Basic Information
10.8.2 Sun Pharma Favipiravir Product Overview
10.8.3 Sun Pharma Favipiravir Product Market Performance
10.8.4 Sun Pharma Business Overview
10.8.5 Sun Pharma Recent Developments
10.9 Hisun Pharm
10.9.1 Hisun Pharm Basic Information
10.9.2 Hisun Pharm Favipiravir Product Overview
10.9.3 Hisun Pharm Favipiravir Product Market Performance
10.9.4 Hisun Pharm Business Overview
10.9.5 Hisun Pharm Recent Developments
11 FAVIPIRAVIR MARKET FORECAST BY REGION
11.1 Global Favipiravir Market Size Forecast
11.2 Global Favipiravir Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Favipiravir Market Size Forecast by Country
11.2.3 Asia Pacific Favipiravir Market Size Forecast by Region
11.2.4 South America Favipiravir Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Favipiravir by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Favipiravir Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Favipiravir by Type (2026-2033)
12.1.2 Global Favipiravir Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Favipiravir by Type (2026-2033)
12.2 Global Favipiravir Market Forecast by Application (2026-2033)
12.2.1 Global Favipiravir Sales (K MT) Forecast by Application
12.2.2 Global Favipiravir Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Favipiravir
1.2 Key Market Segments
1.2.1 Favipiravir Segment by Type
1.2.2 Favipiravir Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 FAVIPIRAVIR MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Favipiravir Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Favipiravir Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 FAVIPIRAVIR MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Favipiravir Product Life Cycle
3.3 Global Favipiravir Sales by Manufacturers (2020-2025)
3.4 Global Favipiravir Revenue Market Share by Manufacturers (2020-2025)
3.5 Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Favipiravir Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Favipiravir Market Competitive Situation and Trends
3.8.1 Favipiravir Market Concentration Rate
3.8.2 Global 5 and 10 Largest Favipiravir Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 FAVIPIRAVIR INDUSTRY CHAIN ANALYSIS
4.1 Favipiravir Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF FAVIPIRAVIR MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Favipiravir Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Favipiravir Market
5.7 ESG Ratings of Leading Companies
6 FAVIPIRAVIR MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Favipiravir Sales Market Share by Type (2020-2025)
6.3 Global Favipiravir Market Size Market Share by Type (2020-2025)
6.4 Global Favipiravir Price by Type (2020-2025)
7 FAVIPIRAVIR MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Favipiravir Market Sales by Application (2020-2025)
7.3 Global Favipiravir Market Size (M USD) by Application (2020-2025)
7.4 Global Favipiravir Sales Growth Rate by Application (2020-2025)
8 FAVIPIRAVIR MARKET SALES BY REGION
8.1 Global Favipiravir Sales by Region
8.1.1 Global Favipiravir Sales by Region
8.1.2 Global Favipiravir Sales Market Share by Region
8.2 Global Favipiravir Market Size by Region
8.2.1 Global Favipiravir Market Size by Region
8.2.2 Global Favipiravir Market Size Market Share by Region
8.3 North America
8.3.1 North America Favipiravir Sales by Country
8.3.2 North America Favipiravir Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Favipiravir Sales by Country
8.4.2 Europe Favipiravir Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Favipiravir Sales by Region
8.5.2 Asia Pacific Favipiravir Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Favipiravir Sales by Country
8.6.2 South America Favipiravir Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Favipiravir Sales by Region
8.7.2 Middle East and Africa Favipiravir Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 FAVIPIRAVIR MARKET PRODUCTION BY REGION
9.1 Global Production of Favipiravir by Region(2020-2025)
9.2 Global Favipiravir Revenue Market Share by Region (2020-2025)
9.3 Global Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Favipiravir Production
9.4.1 North America Favipiravir Production Growth Rate (2020-2025)
9.4.2 North America Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Favipiravir Production
9.5.1 Europe Favipiravir Production Growth Rate (2020-2025)
9.5.2 Europe Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Favipiravir Production (2020-2025)
9.6.1 Japan Favipiravir Production Growth Rate (2020-2025)
9.6.2 Japan Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Favipiravir Production (2020-2025)
9.7.1 China Favipiravir Production Growth Rate (2020-2025)
9.7.2 China Favipiravir Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 ChemRar Group
10.1.1 ChemRar Group Basic Information
10.1.2 ChemRar Group Favipiravir Product Overview
10.1.3 ChemRar Group Favipiravir Product Market Performance
10.1.4 ChemRar Group Business Overview
10.1.5 ChemRar Group SWOT Analysis
10.1.6 ChemRar Group Recent Developments
10.2 Glenmark
10.2.1 Glenmark Basic Information
10.2.2 Glenmark Favipiravir Product Overview
10.2.3 Glenmark Favipiravir Product Market Performance
10.2.4 Glenmark Business Overview
10.2.5 Glenmark SWOT Analysis
10.2.6 Glenmark Recent Developments
10.3 Fujifilm
10.3.1 Fujifilm Basic Information
10.3.2 Fujifilm Favipiravir Product Overview
10.3.3 Fujifilm Favipiravir Product Market Performance
10.3.4 Fujifilm Business Overview
10.3.5 Fujifilm SWOT Analysis
10.3.6 Fujifilm Recent Developments
10.4 Dr. Reddy
10.4.1 Dr. Reddy Basic Information
10.4.2 Dr. Reddy Favipiravir Product Overview
10.4.3 Dr. Reddy Favipiravir Product Market Performance
10.4.4 Dr. Reddy Business Overview
10.4.5 Dr. Reddy Recent Developments
10.5 R-Pharma
10.5.1 R-Pharma Basic Information
10.5.2 R-Pharma Favipiravir Product Overview
10.5.3 R-Pharma Favipiravir Product Market Performance
10.5.4 R-Pharma Business Overview
10.5.5 R-Pharma Recent Developments
10.6 Cipla
10.6.1 Cipla Basic Information
10.6.2 Cipla Favipiravir Product Overview
10.6.3 Cipla Favipiravir Product Market Performance
10.6.4 Cipla Business Overview
10.6.5 Cipla Recent Developments
10.7 Lupin
10.7.1 Lupin Basic Information
10.7.2 Lupin Favipiravir Product Overview
10.7.3 Lupin Favipiravir Product Market Performance
10.7.4 Lupin Business Overview
10.7.5 Lupin Recent Developments
10.8 Sun Pharma
10.8.1 Sun Pharma Basic Information
10.8.2 Sun Pharma Favipiravir Product Overview
10.8.3 Sun Pharma Favipiravir Product Market Performance
10.8.4 Sun Pharma Business Overview
10.8.5 Sun Pharma Recent Developments
10.9 Hisun Pharm
10.9.1 Hisun Pharm Basic Information
10.9.2 Hisun Pharm Favipiravir Product Overview
10.9.3 Hisun Pharm Favipiravir Product Market Performance
10.9.4 Hisun Pharm Business Overview
10.9.5 Hisun Pharm Recent Developments
11 FAVIPIRAVIR MARKET FORECAST BY REGION
11.1 Global Favipiravir Market Size Forecast
11.2 Global Favipiravir Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Favipiravir Market Size Forecast by Country
11.2.3 Asia Pacific Favipiravir Market Size Forecast by Region
11.2.4 South America Favipiravir Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Favipiravir by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Favipiravir Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Favipiravir by Type (2026-2033)
12.1.2 Global Favipiravir Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Favipiravir by Type (2026-2033)
12.2 Global Favipiravir Market Forecast by Application (2026-2033)
12.2.1 Global Favipiravir Sales (K MT) Forecast by Application
12.2.2 Global Favipiravir Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Favipiravir Market Size Comparison by Region (M USD)
Table 5. Global Favipiravir Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Favipiravir Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Favipiravir Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Favipiravir Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir as of 2024)
Table 10. Global Market Favipiravir Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Favipiravir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Favipiravir Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Favipiravir Sales by Type (K MT)
Table 26. Global Favipiravir Market Size by Type (M USD)
Table 27. Global Favipiravir Sales (K MT) by Type (2020-2025)
Table 28. Global Favipiravir Sales Market Share by Type (2020-2025)
Table 29. Global Favipiravir Market Size (M USD) by Type (2020-2025)
Table 30. Global Favipiravir Market Size Share by Type (2020-2025)
Table 31. Global Favipiravir Price (USD/KG) by Type (2020-2025)
Table 32. Global Favipiravir Sales (K MT) by Application
Table 33. Global Favipiravir Market Size by Application
Table 34. Global Favipiravir Sales by Application (2020-2025) & (K MT)
Table 35. Global Favipiravir Sales Market Share by Application (2020-2025)
Table 36. Global Favipiravir Market Size by Application (2020-2025) & (M USD)
Table 37. Global Favipiravir Market Share by Application (2020-2025)
Table 38. Global Favipiravir Sales Growth Rate by Application (2020-2025)
Table 39. Global Favipiravir Sales by Region (2020-2025) & (K MT)
Table 40. Global Favipiravir Sales Market Share by Region (2020-2025)
Table 41. Global Favipiravir Market Size by Region (2020-2025) & (M USD)
Table 42. Global Favipiravir Market Size Market Share by Region (2020-2025)
Table 43. North America Favipiravir Sales by Country (2020-2025) & (K MT)
Table 44. North America Favipiravir Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Favipiravir Sales by Country (2020-2025) & (K MT)
Table 46. Europe Favipiravir Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Favipiravir Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Favipiravir Market Size by Region (2020-2025) & (M USD)
Table 49. South America Favipiravir Sales by Country (2020-2025) & (K MT)
Table 50. South America Favipiravir Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Favipiravir Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Favipiravir Market Size by Region (2020-2025) & (M USD)
Table 53. Global Favipiravir Production (K MT) by Region(2020-2025)
Table 54. Global Favipiravir Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Favipiravir Revenue Market Share by Region (2020-2025)
Table 56. Global Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. ChemRar Group Basic Information
Table 62. ChemRar Group Favipiravir Product Overview
Table 63. ChemRar Group Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. ChemRar Group Business Overview
Table 65. ChemRar Group SWOT Analysis
Table 66. ChemRar Group Recent Developments
Table 67. Glenmark Basic Information
Table 68. Glenmark Favipiravir Product Overview
Table 69. Glenmark Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Glenmark Business Overview
Table 71. Glenmark SWOT Analysis
Table 72. Glenmark Recent Developments
Table 73. Fujifilm Basic Information
Table 74. Fujifilm Favipiravir Product Overview
Table 75. Fujifilm Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Fujifilm Business Overview
Table 77. Fujifilm SWOT Analysis
Table 78. Fujifilm Recent Developments
Table 79. Dr. Reddy Basic Information
Table 80. Dr. Reddy Favipiravir Product Overview
Table 81. Dr. Reddy Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Dr. Reddy Business Overview
Table 83. Dr. Reddy Recent Developments
Table 84. R-Pharma Basic Information
Table 85. R-Pharma Favipiravir Product Overview
Table 86. R-Pharma Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. R-Pharma Business Overview
Table 88. R-Pharma Recent Developments
Table 89. Cipla Basic Information
Table 90. Cipla Favipiravir Product Overview
Table 91. Cipla Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Cipla Business Overview
Table 93. Cipla Recent Developments
Table 94. Lupin Basic Information
Table 95. Lupin Favipiravir Product Overview
Table 96. Lupin Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Lupin Business Overview
Table 98. Lupin Recent Developments
Table 99. Sun Pharma Basic Information
Table 100. Sun Pharma Favipiravir Product Overview
Table 101. Sun Pharma Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Sun Pharma Business Overview
Table 103. Sun Pharma Recent Developments
Table 104. Hisun Pharm Basic Information
Table 105. Hisun Pharm Favipiravir Product Overview
Table 106. Hisun Pharm Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Hisun Pharm Business Overview
Table 108. Hisun Pharm Recent Developments
Table 109. Global Favipiravir Sales Forecast by Region (2026-2033) & (K MT)
Table 110. Global Favipiravir Market Size Forecast by Region (2026-2033) & (M USD)
Table 111. North America Favipiravir Sales Forecast by Country (2026-2033) & (K MT)
Table 112. North America Favipiravir Market Size Forecast by Country (2026-2033) & (M USD)
Table 113. Europe Favipiravir Sales Forecast by Country (2026-2033) & (K MT)
Table 114. Europe Favipiravir Market Size Forecast by Country (2026-2033) & (M USD)
Table 115. Asia Pacific Favipiravir Sales Forecast by Region (2026-2033) & (K MT)
Table 116. Asia Pacific Favipiravir Market Size Forecast by Region (2026-2033) & (M USD)
Table 117. South America Favipiravir Sales Forecast by Country (2026-2033) & (K MT)
Table 118. South America Favipiravir Market Size Forecast by Country (2026-2033) & (M USD)
Table 119. Middle East and Africa Favipiravir Sales Forecast by Country (2026-2033) & (Units)
Table 120. Middle East and Africa Favipiravir Market Size Forecast by Country (2026-2033) & (M USD)
Table 121. Global Favipiravir Sales Forecast by Type (2026-2033) & (K MT)
Table 122. Global Favipiravir Market Size Forecast by Type (2026-2033) & (M USD)
Table 123. Global Favipiravir Price Forecast by Type (2026-2033) & (USD/KG)
Table 124. Global Favipiravir Sales (K MT) Forecast by Application (2026-2033)
Table 125. Global Favipiravir Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Favipiravir Market Size Comparison by Region (M USD)
Table 5. Global Favipiravir Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Favipiravir Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Favipiravir Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Favipiravir Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir as of 2024)
Table 10. Global Market Favipiravir Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Favipiravir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Favipiravir Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Favipiravir Sales by Type (K MT)
Table 26. Global Favipiravir Market Size by Type (M USD)
Table 27. Global Favipiravir Sales (K MT) by Type (2020-2025)
Table 28. Global Favipiravir Sales Market Share by Type (2020-2025)
Table 29. Global Favipiravir Market Size (M USD) by Type (2020-2025)
Table 30. Global Favipiravir Market Size Share by Type (2020-2025)
Table 31. Global Favipiravir Price (USD/KG) by Type (2020-2025)
Table 32. Global Favipiravir Sales (K MT) by Application
Table 33. Global Favipiravir Market Size by Application
Table 34. Global Favipiravir Sales by Application (2020-2025) & (K MT)
Table 35. Global Favipiravir Sales Market Share by Application (2020-2025)
Table 36. Global Favipiravir Market Size by Application (2020-2025) & (M USD)
Table 37. Global Favipiravir Market Share by Application (2020-2025)
Table 38. Global Favipiravir Sales Growth Rate by Application (2020-2025)
Table 39. Global Favipiravir Sales by Region (2020-2025) & (K MT)
Table 40. Global Favipiravir Sales Market Share by Region (2020-2025)
Table 41. Global Favipiravir Market Size by Region (2020-2025) & (M USD)
Table 42. Global Favipiravir Market Size Market Share by Region (2020-2025)
Table 43. North America Favipiravir Sales by Country (2020-2025) & (K MT)
Table 44. North America Favipiravir Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Favipiravir Sales by Country (2020-2025) & (K MT)
Table 46. Europe Favipiravir Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Favipiravir Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Favipiravir Market Size by Region (2020-2025) & (M USD)
Table 49. South America Favipiravir Sales by Country (2020-2025) & (K MT)
Table 50. South America Favipiravir Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Favipiravir Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Favipiravir Market Size by Region (2020-2025) & (M USD)
Table 53. Global Favipiravir Production (K MT) by Region(2020-2025)
Table 54. Global Favipiravir Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Favipiravir Revenue Market Share by Region (2020-2025)
Table 56. Global Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Favipiravir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. ChemRar Group Basic Information
Table 62. ChemRar Group Favipiravir Product Overview
Table 63. ChemRar Group Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. ChemRar Group Business Overview
Table 65. ChemRar Group SWOT Analysis
Table 66. ChemRar Group Recent Developments
Table 67. Glenmark Basic Information
Table 68. Glenmark Favipiravir Product Overview
Table 69. Glenmark Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Glenmark Business Overview
Table 71. Glenmark SWOT Analysis
Table 72. Glenmark Recent Developments
Table 73. Fujifilm Basic Information
Table 74. Fujifilm Favipiravir Product Overview
Table 75. Fujifilm Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Fujifilm Business Overview
Table 77. Fujifilm SWOT Analysis
Table 78. Fujifilm Recent Developments
Table 79. Dr. Reddy Basic Information
Table 80. Dr. Reddy Favipiravir Product Overview
Table 81. Dr. Reddy Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Dr. Reddy Business Overview
Table 83. Dr. Reddy Recent Developments
Table 84. R-Pharma Basic Information
Table 85. R-Pharma Favipiravir Product Overview
Table 86. R-Pharma Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. R-Pharma Business Overview
Table 88. R-Pharma Recent Developments
Table 89. Cipla Basic Information
Table 90. Cipla Favipiravir Product Overview
Table 91. Cipla Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Cipla Business Overview
Table 93. Cipla Recent Developments
Table 94. Lupin Basic Information
Table 95. Lupin Favipiravir Product Overview
Table 96. Lupin Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Lupin Business Overview
Table 98. Lupin Recent Developments
Table 99. Sun Pharma Basic Information
Table 100. Sun Pharma Favipiravir Product Overview
Table 101. Sun Pharma Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Sun Pharma Business Overview
Table 103. Sun Pharma Recent Developments
Table 104. Hisun Pharm Basic Information
Table 105. Hisun Pharm Favipiravir Product Overview
Table 106. Hisun Pharm Favipiravir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Hisun Pharm Business Overview
Table 108. Hisun Pharm Recent Developments
Table 109. Global Favipiravir Sales Forecast by Region (2026-2033) & (K MT)
Table 110. Global Favipiravir Market Size Forecast by Region (2026-2033) & (M USD)
Table 111. North America Favipiravir Sales Forecast by Country (2026-2033) & (K MT)
Table 112. North America Favipiravir Market Size Forecast by Country (2026-2033) & (M USD)
Table 113. Europe Favipiravir Sales Forecast by Country (2026-2033) & (K MT)
Table 114. Europe Favipiravir Market Size Forecast by Country (2026-2033) & (M USD)
Table 115. Asia Pacific Favipiravir Sales Forecast by Region (2026-2033) & (K MT)
Table 116. Asia Pacific Favipiravir Market Size Forecast by Region (2026-2033) & (M USD)
Table 117. South America Favipiravir Sales Forecast by Country (2026-2033) & (K MT)
Table 118. South America Favipiravir Market Size Forecast by Country (2026-2033) & (M USD)
Table 119. Middle East and Africa Favipiravir Sales Forecast by Country (2026-2033) & (Units)
Table 120. Middle East and Africa Favipiravir Market Size Forecast by Country (2026-2033) & (M USD)
Table 121. Global Favipiravir Sales Forecast by Type (2026-2033) & (K MT)
Table 122. Global Favipiravir Market Size Forecast by Type (2026-2033) & (M USD)
Table 123. Global Favipiravir Price Forecast by Type (2026-2033) & (USD/KG)
Table 124. Global Favipiravir Sales (K MT) Forecast by Application (2026-2033)
Table 125. Global Favipiravir Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Favipiravir
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Favipiravir Market Size (M USD), 2024-2033
Figure 5. Global Favipiravir Market Size (M USD) (2020-2033)
Figure 6. Global Favipiravir Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Favipiravir Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Favipiravir Product Life Cycle
Figure 13. Favipiravir Sales Share by Manufacturers in 2024
Figure 14. Global Favipiravir Revenue Share by Manufacturers in 2024
Figure 15. Favipiravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Favipiravir Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Favipiravir Revenue in 2024
Figure 18. Industry Chain Map of Favipiravir
Figure 19. Global Favipiravir Market PEST Analysis
Figure 20. Global Favipiravir Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Favipiravir Market Share by Type
Figure 27. Sales Market Share of Favipiravir by Type (2020-2025)
Figure 28. Sales Market Share of Favipiravir by Type in 2024
Figure 29. Market Size Share of Favipiravir by Type (2020-2025)
Figure 30. Market Size Share of Favipiravir by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Favipiravir Market Share by Application
Figure 33. Global Favipiravir Sales Market Share by Application (2020-2025)
Figure 34. Global Favipiravir Sales Market Share by Application in 2024
Figure 35. Global Favipiravir Market Share by Application (2020-2025)
Figure 36. Global Favipiravir Market Share by Application in 2024
Figure 37. Global Favipiravir Sales Growth Rate by Application (2020-2025)
Figure 38. Global Favipiravir Sales Market Share by Region (2020-2025)
Figure 39. Global Favipiravir Market Size Market Share by Region (2020-2025)
Figure 40. North America Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Favipiravir Sales Market Share by Country in 2024
Figure 43. North America Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Favipiravir Market Size Market Share by Country in 2024
Figure 45. U.S. Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Favipiravir Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Favipiravir Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Favipiravir Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Favipiravir Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Favipiravir Sales Market Share by Country in 2024
Figure 53. Europe Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Favipiravir Market Size Market Share by Country in 2024
Figure 55. Germany Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Favipiravir Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Favipiravir Sales Market Share by Region in 2024
Figure 67. Asia Pacific Favipiravir Market Size Market Share by Region in 2024
Figure 68. China Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Favipiravir Sales and Growth Rate (K MT)
Figure 79. South America Favipiravir Sales Market Share by Country in 2024
Figure 80. South America Favipiravir Market Size and Growth Rate (M USD)
Figure 81. South America Favipiravir Market Size Market Share by Country in 2024
Figure 82. Brazil Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Favipiravir Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Favipiravir Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Favipiravir Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Favipiravir Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Favipiravir Production Market Share by Region (2020-2025)
Figure 103. North America Favipiravir Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Favipiravir Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Favipiravir Production (K MT) Growth Rate (2020-2025)
Figure 106. China Favipiravir Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Favipiravir Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Favipiravir Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Favipiravir Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Favipiravir Market Share Forecast by Type (2026-2033)
Figure 111. Global Favipiravir Sales Forecast by Application (2026-2033)
Figure 112. Global Favipiravir Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Favipiravir
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Favipiravir Market Size (M USD), 2024-2033
Figure 5. Global Favipiravir Market Size (M USD) (2020-2033)
Figure 6. Global Favipiravir Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Favipiravir Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Favipiravir Product Life Cycle
Figure 13. Favipiravir Sales Share by Manufacturers in 2024
Figure 14. Global Favipiravir Revenue Share by Manufacturers in 2024
Figure 15. Favipiravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Favipiravir Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Favipiravir Revenue in 2024
Figure 18. Industry Chain Map of Favipiravir
Figure 19. Global Favipiravir Market PEST Analysis
Figure 20. Global Favipiravir Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Favipiravir Market Share by Type
Figure 27. Sales Market Share of Favipiravir by Type (2020-2025)
Figure 28. Sales Market Share of Favipiravir by Type in 2024
Figure 29. Market Size Share of Favipiravir by Type (2020-2025)
Figure 30. Market Size Share of Favipiravir by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Favipiravir Market Share by Application
Figure 33. Global Favipiravir Sales Market Share by Application (2020-2025)
Figure 34. Global Favipiravir Sales Market Share by Application in 2024
Figure 35. Global Favipiravir Market Share by Application (2020-2025)
Figure 36. Global Favipiravir Market Share by Application in 2024
Figure 37. Global Favipiravir Sales Growth Rate by Application (2020-2025)
Figure 38. Global Favipiravir Sales Market Share by Region (2020-2025)
Figure 39. Global Favipiravir Market Size Market Share by Region (2020-2025)
Figure 40. North America Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Favipiravir Sales Market Share by Country in 2024
Figure 43. North America Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Favipiravir Market Size Market Share by Country in 2024
Figure 45. U.S. Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Favipiravir Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Favipiravir Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Favipiravir Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Favipiravir Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Favipiravir Sales Market Share by Country in 2024
Figure 53. Europe Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Favipiravir Market Size Market Share by Country in 2024
Figure 55. Germany Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Favipiravir Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Favipiravir Sales Market Share by Region in 2024
Figure 67. Asia Pacific Favipiravir Market Size Market Share by Region in 2024
Figure 68. China Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Favipiravir Sales and Growth Rate (K MT)
Figure 79. South America Favipiravir Sales Market Share by Country in 2024
Figure 80. South America Favipiravir Market Size and Growth Rate (M USD)
Figure 81. South America Favipiravir Market Size Market Share by Country in 2024
Figure 82. Brazil Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Favipiravir Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Favipiravir Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Favipiravir Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Favipiravir Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Favipiravir Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Favipiravir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Favipiravir Production Market Share by Region (2020-2025)
Figure 103. North America Favipiravir Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Favipiravir Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Favipiravir Production (K MT) Growth Rate (2020-2025)
Figure 106. China Favipiravir Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Favipiravir Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Favipiravir Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Favipiravir Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Favipiravir Market Share Forecast by Type (2026-2033)
Figure 111. Global Favipiravir Sales Forecast by Application (2026-2033)
Figure 112. Global Favipiravir Market Share Forecast by Application (2026-2033)
